Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
SNYR 
Synergy CHC Corp. Common Stock (SNYR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/05/2025: SNYR (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $10
1 Year Target Price $10
| 0 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 23.77% | Avg. Invested days 41 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  5.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 11/05/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 24.57M USD | Price to earnings Ratio 5.78 | 1Y Target Price 10 |
Price to earnings Ratio 5.78 | 1Y Target Price 10 | ||
Volume (30-day avg) 1 | Beta 0.86 | 52 Weeks Range 1.30 - 7.65 | Updated Date 11/7/2025 |
52 Weeks Range 1.30 - 7.65 | Updated Date 11/7/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.38 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 9.61% | Operating Margin (TTM) 19.96% |
Management Effectiveness
Return on Assets (TTM) 24.16% | Return on Equity (TTM) -361.12% |
Valuation
Trailing PE 5.78 | Forward PE 5.51 | Enterprise Value 53171090 | Price to Sales(TTM) 0.73 |
Enterprise Value 53171090 | Price to Sales(TTM) 0.73 | ||
Enterprise Value to Revenue 1.58 | Enterprise Value to EBITDA 6.04 | Shares Outstanding 11191853 | Shares Floating 4053104 |
Shares Outstanding 11191853 | Shares Floating 4053104 | ||
Percent Insiders 56.75 | Percent Institutions 3.98 |
Upturn AI SWOT
Synergy CHC Corp. Common Stock
Company Overview
History and Background
Synergy CHC Corp. ceased operations in 2020 and filed for bankruptcy. The company was previously focused on acquiring and marketing consumer healthcare brands.
Core Business Areas
- Branded Consumer Health Products: Synergy CHC marketed various over-the-counter (OTC) healthcare products, including cough/cold remedies, vitamins, and supplements.
Leadership and Structure
Prior to its closure, Synergy CHC had a standard corporate structure with a CEO and board of directors. The company is now defunct.
Top Products and Market Share
Key Offerings
- Breathe Right Nasal Strips: Breathe Right nasal strips were one of Synergy CHC's key products. The market share was significant in the nasal strip category. Competitors included generic brands and other nasal decongestant products. No specific market share available due to the company's dissolution.
Market Dynamics
Industry Overview
The consumer healthcare industry is characterized by intense competition, evolving consumer preferences, and regulatory scrutiny. It includes a wide range of OTC drugs, vitamins, supplements, and personal care products.
Positioning
Before its bankruptcy, Synergy CHC aimed to grow through acquisitions and brand revitalization. It faced challenges competing with larger, more established players.
Total Addressable Market (TAM)
TAM for the consumer healthcare market is substantial, worth billions of dollars globally. Synergy CHC had a small piece of this TAM and was positioned as a brand acquirer and revitalizer.
Upturn SWOT Analysis
Strengths
- Established Brand Portfolio (prior to closure)
- Acquisition Expertise (prior to closure)
Weaknesses
- High Debt Load (prior to closure)
- Limited Scale Compared to Competitors (prior to closure)
- Inefficient operations (prior to closure)
Opportunities
- Growing Demand for OTC Healthcare (prior to closure)
- Acquisition of Undervalued Brands (prior to closure)
Threats
- Intense Competition
- Changing Regulatory Landscape
- Economic Downturn
Competitors and Market Share
Key Competitors
- PG
- JNJ
- KMB
Competitive Landscape
Synergy CHC struggled to compete with larger, more established players in the consumer healthcare market.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is irrelevant due to Synergy CHC's bankruptcy.
Future Projections: Future projections are irrelevant due to Synergy CHC's bankruptcy.
Recent Initiatives: Recent Initiatives are irrelevant due to Synergy CHC's bankruptcy.
Summary
Synergy CHC Corp. is no longer in operation and filed for bankruptcy. Its historical focus was on acquiring and marketing consumer healthcare brands, but it faced challenges due to high debt and intense competition. The company's financial performance deteriorated, ultimately leading to its downfall. Investors should be aware of the risks associated with smaller companies in competitive industries.
Similar Stocks
Sources and Disclaimers
Data Sources:
- SEC Filings (historical), News Articles (historical)
Disclaimers:
This analysis is based on historical data prior to Synergy CHC's bankruptcy. The company is no longer in operation. This should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Synergy CHC Corp. Common Stock
Exchange NASDAQ | Headquaters Westbrook, ME, United States | ||
IPO Launch date 2016-01-04 | CEO & Chairman Mr. Jack Ross | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 21 | Website https://synergychc.com |
Full time employees 21 | Website https://synergychc.com | ||
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; and lifestyle and wellness products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name. The company also provides hand care products under the Hand MD brand name; beauty products for the eyes, lips, brows, cheeks, and skin under the Perfekt Beauty brand; shapewear, bralettes, and panties under Sneaky Vaunt brand; eyelash enhancement products under The Queen Pegasus brand; topical treatments for neuropathic pain under Neuragen brand; and over-the-counter medications under UrgentRx brand. It sells its products through club, mass drug, and other retailers. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. The company was incorporated in 2010 and is based in Westbrook, Maine.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.